Targacept Inc. (TRGT) Stock Quote

Detailed Quote for Targacept Inc. (TRGT) 
$ 6.38   0.15 (+2.41%) Volume: 293.04 k 4:00 PM EST Feb 3, 2012
Today 5d 1m 3m 1y more
Last Price
6.38
Change $
0.15
Change %
2.41%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
6.29
High
6.51
Low
6.22
Prev Close
6.23
Last Trade
4:00
Volume
293.04 k
52 Wk Hi
30.47
52 Wk Low
4.9101
Market Cap
212.99 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
33,383,403
EPS (TTM)
N/A
PE Ratio
N/A
Exchange
NGS
News and Media for Targacept Inc.  (TRGT) 
Sector News | Topic News
News for TRGT
Thu, Jan 05, 2012
8:55 AM Targacept Announces Decision by AstraZeneca to Advance AZD1446 in Alzheimer's Disease - Business Wire
Wed, Jan 04, 2012
8:55 AM Targacept to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire
7:00 AM Annual CNS Overview Issue Released by NeuroPerspective - Marketwire
Tue, Dec 20, 2011
2:02 AM AstraZeneca and Targacept Announce Top-line Results from Second Phase 3 Study of TC-5214 as an Adjunct Treatment in Patients with Major Depressive Disorder - Business Wire
Mon, Dec 05, 2011
8:00 AM Targacept Announces Initiation of Two Phase 2 Studies of TC-5619 - Business Wire
Mon, Nov 28, 2011
8:55 AM Targacept Announces Participation in Upcoming Conferences - Business Wire
Fri, Nov 11, 2011
4:05 PM Targacept to Present at the Lazard Capital Markets 8th Annual Healthcare Conference - Business Wire
9:00 AM Europe Situation Forecasts Change -- Report Highlights Wal-Mart Stores, Inc. and Targacept, Inc. - Marketwire
Tue, Nov 08, 2011
2:15 AM Targacept to Host Conference Call Today at 10:00 AM to Discuss Top-line Results from RENAISSANCE 3 Study of TC-5214 as an Adjunct to Antidepressant Treatment for Major Depressive Disorder - Business Wire
2:10 AM AstraZeneca and Targacept Announce First Top-line Phase 3 Results for TC-5214 as an Adjunct Treatment in Patients with Major Depressive Disorder - Business Wire
Thu, Oct 27, 2011
9:00 AM Analyst View, Impact of Global Events - Research Report on Targacept, Inc. and Acme Packet, Inc. - Marketwire
Fri, Oct 07, 2011
9:00 AM Expert's Economic Outlook, Global - Equity Research on Par Pharmaceutical Companies, Inc. and Targacept, Inc. - Marketwire
Mon, Oct 03, 2011
10:57 AM Alzheimer's Therapeutics Reviewed by NeuroPerspective - Marketwire
Tue, Jun 07, 2011
11:02 AM Pain Therapeutics Reviewed by NeuroPerspective - Marketwire
Wed, Apr 06, 2011
6:00 AM Schizophrenia Reviewed by NeuroInvestment - Marketwire
Wed, Mar 02, 2011
8:00 AM Parkinson's Therapeutics Reviewed by NeuroInvestment - Marketwire
More News for TRGT >>

Tags for Targacept Inc.

Research stocks or mutual funds related to Targacept Inc. by keywords or tags. Find companies that have a similar focus to TRGT. The keywords below have been associated to TRGT by either user submission or electronic means.

biotechnology company biotech research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment biotechnology market pharmaceutical research and development dupont pharmaceuticals pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company pharmaceutical cro biopharmaceutical companies pharma companies pharma consulting pharma consultants pharmaceutical distributors company patent biotech pharmaceutical company pharmaceutical development biopharmaceutical company pharmaceutical magazine pharmaceutical consultant Drugs pharmaceutical auctions pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharma reports contract pharmaceutical pharmaceutical consulting pharmaceutical medical packaging news pharmaceutical industry biopharmaceutical market clinical trials europe acetylcholine patent research pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development Healthcare medical and pharmaceutical packaging pharmaceutical sector bio pharmaceuticals

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.